First successful Heartmate 3 TM left ventricular assist device implantation as destination therapy in Argentina
pp 239-243
DOI:
https://doi.org/10.7775/rac.v89i3.581Keywords:
Heart Failure, Heart-Assist Devices, Ventricular Dysfunction, LeftAbstract
First case of successful implantation of intracorporeal full magnetically levitated continuous centrifugal flow left ventricular assist device HeartMate 3 Abbott ® as destination therapy in Argentina in a female patient, 52-years-old with non compaction cardiomyopathy, severe left ventricular dysfunction, pulmonary hypertension, end-stage heart failure INTERMACS 3 and contraindication for heart transplantation due to high titers of preformed antibodies against the HLA system in panel reactive antibody assay.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Argentine Journal of Cardiology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.








